Approaches to antiviral chemotherapy for acute respiratory infections

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 2, 1998, Pages 93-107

  Shigeta, Shiro ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute respiratory infection; Influenza virus; Respiratory syncytial virus; Rhinovirus

Indexed keywords

4 [1 BENZYL 3 (4 CHLOROBENZYL) 3 PIPERIDINYL] 2,4 DIOXOBUTYRIC ACID; AMANTADINE; BL 1743; BMY 27709; DEXTRAN SULFATE; NEURAMINIC ACID; OSELTAMIVIR; OXONIC ACID; PLECONARIL; PM 523; PROTEINASE INHIBITOR; RIBAVIRIN; RIMANTADINE; SCH 48973; UNCLASSIFIED DRUG; ZANAMIVIR;

ANTIVIRAL ACTIVITY; DNA REPLICATION; GENE TARGETING; HUMAN; IMMUNOCOMPETENCE; INFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; VIRUS REPLICATION;

EID: 0031899552     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029800900201     Document Type: Review

References (10)

1. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J & De Clercq E (1988) Mechanism of inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus in vitro. Proceedings of the National Academy of Sciences, USA 85:6132-6136.
2. Barker WH (1986) Excess pneumonia and influenza hospitalization in the US due to influenza epidemics 1970-1978. American Journal of Public Health 76:761-765.
3. Barnard DL, Hill CL, Gage T, Matheson JE, Huffman JH, Sidwell RW, Otto MI & Schinazi RF (1997) Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. Antiviral Research 34:27-37.
4. Belshe RB, Burk B, Newman F, Cerruti RL & Sim IS (1989) Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. Journal of Infectious Diseases 159:430-435.
5. Chadwani S, Brokonsky W, Krasinski K, Lawrence R & Welliver R (1990) Respiratory syncytial virus infection in human immunodeficiency virus infected children. Journal of Pediatrics 117:251-254.
6. Chin J, Magoffin RL, Shearer LA, Schieble JH & Lennette EH (1969). Field evaluation of respiratory syncytial virus vaccine and trivalent parainfluenza vaccine in a pediatric population. American Journal of Epidemiology 89:449-463.
7. Wild C, Greenwell T & Matthews T (1993) A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus mediated cell-cell fusion. AIDS Research and Human Retro-viruses 9:1051-1053.
8. Witkowski JT, Robins RK, Khare GP & Sidwell RW (1973) Synthesis and antiviral activity of l,2,4-triazole-3-thiocarboxamide and l,2,4-triazole-3-carboxiamidine ribonucleoside. Journal of Medicinal Chemistry 16:935-937.
9. Yuasa T, Kwano M, Tabata N, Nishino M, Kusagawa S, Komada K, Matumura H, Ito Y & Turudome M (1995) A cell fusion inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin neuraminidase protein. Virology 206:1117-1125.
10. Yyeryar FJ (1983) Report of a workshop on respiratory syncytial and parainfluenza viruses. Journal of Infectious Diseases 148:588-598.